Paul Y. Song - 06 Dec 2023 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Chief Executive Officer, Director
Signature
/s/ Paul Y. Song
Issuer symbol
NKGN
Transactions as of
06 Dec 2023
Net transactions value
+$500
Form type
4
Filing time
07 Dec 2023, 17:23:12 UTC
Previous filing
05 Dec 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKGN Common Stock Purchase $250 +75 +0.04% $3.32 171,045 06 Dec 2023 Direct
transaction NKGN Common Stock Purchase $250 +76 +0.04% $3.29 171,121 07 Dec 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.